173 related articles for article (PubMed ID: 8606381)
1. Genetic susceptibility to head and neck squamous cell carcinoma.
Cloos J; Spitz MR; Schantz SP; Hsu TC; Zhang ZF; Tobi H; Braakhuis BJ; Snow GB
J Natl Cancer Inst; 1996 Apr; 88(8):530-5. PubMed ID: 8606381
[TBL] [Abstract][Full Text] [Related]
2. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
3. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Hsu TC; Schantz SP
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1043-9. PubMed ID: 11045786
[TBL] [Abstract][Full Text] [Related]
4. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity.
Schantz SP; Zhang ZF; Spitz MS; Sun M; Hsu TC
Laryngoscope; 1997 Jun; 107(6):765-81. PubMed ID: 9185733
[TBL] [Abstract][Full Text] [Related]
6. Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Marshall JR; Hsu TC; Schantz SP
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1071-8. PubMed ID: 10613339
[TBL] [Abstract][Full Text] [Related]
7. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck.
Xiong P; Hu Z; Li C; Wang LE; El-Naggar AK; Sturgis EM; Wei Q
Int J Cancer; 2007 Dec; 121(12):2735-40. PubMed ID: 17724733
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
9. Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers.
Schantz SP; Huang Q; Shah K; Murty VV; Hsu TC; Yu G; Andersen PE; Huvos AG; Chaganti RS
Carcinogenesis; 2000 Jun; 21(6):1239-46. PubMed ID: 10837016
[TBL] [Abstract][Full Text] [Related]
10. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
[TBL] [Abstract][Full Text] [Related]
11. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer.
Yu GP; Zhang ZF; Hsu TC; Spitz MR; Schantz SP
Cancer Lett; 1999 Nov; 146(1):93-101. PubMed ID: 10656614
[TBL] [Abstract][Full Text] [Related]
12. Mutagen sensitivity of patients with cancer at different sites of the head and neck.
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2005 Sep; 20(5):381-5. PubMed ID: 16105906
[TBL] [Abstract][Full Text] [Related]
13. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
14. Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma.
Ko JY; Lui LT; Sheen TS; Lou PJ; Hsu MM
Arch Otolaryngol Head Neck Surg; 1998 May; 124(5):578-81. PubMed ID: 9604986
[TBL] [Abstract][Full Text] [Related]
15. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes.
Cloos J; Nieuwenhuis EJ; Boomsma DI; Kuik DJ; van der Sterre ML; Arwert F; Snow GB; Braakhuis BJ
J Natl Cancer Inst; 1999 Jul; 91(13):1125-30. PubMed ID: 10393720
[TBL] [Abstract][Full Text] [Related]
16. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
17. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract.
Spitz MR; Hoque A; Trizna Z; Schantz SP; Amos CI; King TM; Bondy ML; Hong WK; Hsu TC
J Natl Cancer Inst; 1994 Nov; 86(22):1681-4. PubMed ID: 7966395
[TBL] [Abstract][Full Text] [Related]
18. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.
Spitz MR; Fueger JJ; Halabi S; Schantz SP; Sample D; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):329-33. PubMed ID: 7688625
[TBL] [Abstract][Full Text] [Related]
19. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage.
Schantz SP; Hsu TC; Ainslie N; Moser RP
JAMA; 1989 Dec; 262(23):3313-5. PubMed ID: 2479781
[TBL] [Abstract][Full Text] [Related]
20. Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma.
Aben KK; Cloos J; Koper NP; Braakhuis BJ; Witjes JA; Kiemeney LA
Int J Cancer; 2000 Nov; 88(3):493-6. PubMed ID: 11054683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
